Andersen, S. W., Trentham-Dietz, A., Figueroa, J. D., Titus, L. J., Cai, Q., Long, J., . . . Newcomb, P. A. (2013). Breast cancer susceptibility associated with rs1219648 (FGFR2) and postmenopausal hormone therapy use in a population-based U.S. study.

Andersen, Shaneda Warren, Amy Trentham-Dietz, Jonine D. Figueroa, Linda J. Titus, Qiuyin Cai, Jirong Long, John M. Hampton, Kathleen M. Egan, a Polly A. Newcomb. Breast Cancer Susceptibility Associated With Rs1219648 (FGFR2) and Postmenopausal Hormone Therapy Use in a Population-based U.S. Study. 2013.

Andersen, Shaneda Warren, et al. Breast Cancer Susceptibility Associated With Rs1219648 (FGFR2) and Postmenopausal Hormone Therapy Use in a Population-based U.S. Study. 2013.